Key Factors to Consider Before Investing in Universal Health Services (UHS)

Shares of Universal Health Services have moved -2.4% today, and are now trading at a price of $180.93. In contrast, the S&P 500 index saw a 1.0% change. Today's trading volume is 893,054 compared to the stock's average volume of 675,311.

Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. Based in King of Prussia, United States the company has 96,700 full time employees and a market cap of $12,109,499,392. Universal Health Services currently offers its equity investors a dividend that yields 0.4% per year.

The company is now trading -8.31% away from its average analyst target price of $197.33 per share. The 15 analysts following the stock have set target prices ranging from $156.0 to $236.0, and on average give Universal Health Services a rating of buy.

Over the last 52 weeks, UHS stock has risen 17.8%, which amounts to a -8.5% difference compared to the S&P 500. The stock's 52 week high is $194.02 whereas its 52 week low is $119.9 per share. With its net margins declining an average -5.4% over the last 6 years, Universal Health Services may not have a strong enough profitability trend to support its stock price.

Date Reported Total Revenue ($ k) Net Profit ($ k) Net Margins (%) YoY Growth (%)
2023 14,281,976 717,795 5 0.0
2022 13,399,370 675,609 5 -37.5
2021 12,642,117 991,590 8 0.0
2020 11,558,897 943,953 8 14.29
2019 11,378,259 814,854 7 0.0
2018 10,772,278 779,705 7
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.